BioteBTMD -8.21%66 OCF Yield % is 59.60 as of Jun. 27, 2026, which is 202% above its 10-year median of 19.75. GuruFocus rates BTMD with a GF Score™ of 66/100 and a GF Value™ of $3.07 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Biote ranks better than 97.23% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Biote OCF Yield % Related Terms
Biote OCF Yield % Historical Data
* Premium members only.
The historical data trend for Biote's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Biote's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biote OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Biote's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Biote's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biote (BTMD) has a OCF Yield % of 59.60 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Biote and its competitors. This is 202% above median its historical median of 19.75. According to the industry distribution chart, Biote ranks #19 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 2.8%.
Is Biote's OCF Yield % too high?
Biote's current OCF Yield % of 59.60 is 202% above median its 10-year median of 19.75. The Healthcare Providers & Services industry median OCF Yield % is 5.56. Biote's value of 59.60 is 972.9% above this industry median. Based on the distribution chart, Biote ranks #19 out of 686 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Biote has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biote's OCF Yield % compare to DCGO and PIII?
According to the Healthcare Providers & Services industry distribution chart, Biote ranks #19 out of 686 companies for OCF Yield %. This places Biote in the top 3% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.56. Biote's value of 59.60 is 972.9% above this benchmark. While the company's 10-year median is 19.75 vs. the industry median of 5.56, Biote has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.56, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biote's current OCF Yield % of 59.60 is 972.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Biote and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biote's current OCF Yield % is 59.60, which is 202% above median its own 10-year median of 19.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biote stock overvalued right now?
Based on GuruFocus' analysis, Biote (BTMD) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.07, compared to a current price of $1.81 — trading 41.2% below its estimated fair value. The current OCF Yield % is 59.60, which is 202% above median its 10-year median of 19.75 and 972.9% above the Healthcare Providers & Services industry median of 5.56. Biote's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Biote (BTMD), the current OCF Yield % is 59.60 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biote (BTMD) Overvalued in 2026?
Based on GuruFocus' analysis, Biote stock appears to be undervalued.
The current stock price of $1.81 is trading 41.2% below its estimated GF Value™ of $3.07.
GuruFocus considers Biote to be Significantly Undervalued.
Key valuation signals for BTMD:
OCF Yield %: 59.60 (202% above median its 10-year median of 19.75)
GF Value™: $3.07 vs. price of $1.81 (41.2% below fair value)
Industry Position: 972.9% above the Healthcare Providers & Services median (#19 of 686)
No single metric tells the full story. See the BTMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
66GF Score
Get the complete analysis for BTMD
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BTMD has been successfully added to your 
